Company / Working Capital
Immunocore Holdings plc Working Capital History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$750.0M
FY2025
5-year range
$373.1M / $750.0M
FY2022-FY2025
Trend
+4.5%
vs FY2024
Sector context
#57 of 213
Health Care
What the data says
At $750M, Immunocore Holdings plc's working capital ranks #57 of 213 in the Health Care sector. Working Capital has increased for 3 consecutive years, from $373M in FY2022 to $750M in FY2025.
Based on SEC 10-K filings.
$750M in FY2025 with a 3-year CAGR of +26.2%.
Improved from $390M to $750M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +26.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#57 of 213 in Health CareTop 27% of 213This company $750.0M Sector average $934.6M
▼
-19.7% below sector average
Key checks
Key Insights
- Immunocore Holdings plc's working capital has grown for 3 consecutive years.
- 3-year CAGR of +26.2%, indicating consistent growth.
- In FY2025, working capital increased 4.5% year-over-year.
- Ranks #57 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $750.0M | +4.5% |
| FY2024 | $717.7M | +84.1% |
| FY2023 | $389.8M | +4.5% |
| FY2022 | $373.1M | - |
| FY2021 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026